DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Stone L, Merriman E, Hanna M, Royle G, Chan H.
Retrospective analysis of the effectiveness of a reduced dose of idarucizumab in dabigatran reversal.
Thromb Haemost 2022;
122 (07) 1096-1103
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.